LIBRAX: CHLORDIAZEPOXIDE HYDROCHLORIDE A.
CHLORDIAZEPOXIDE HYDROCHLORIDE A. Key specifications include capsule_type: HARD, capsule_content_form: POWDER, primary_container_type: BOTTLE, part_name_assigned_by_controlling_agency: CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE, capsule_primary_container_content_quantity: 500.000. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-074-4692, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| capsule_type | HARD |
| capsule_content_form | POWDER |
| primary_container_type | BOTTLE |
| active_medicament_medicinal_strength | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE |
| capsule_primary_container_content_quantity | 500.000 |
| NSN | 6505-00-074-4692 |
| PRIMARY CONTAINER TYPE | BOTTLE |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 500.000 |
| CAPSULE TYPE | HARD |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE |
| CAPSULE CONTENT FORM | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |